Dopamine Hydrochloride In Dextrose Injection, Solution
Product Images NDC 51662-1681

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride In Dextrose (NDC 51662-1681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1681 Structure 1)

Chemical structure diagram of dopamine hydrochloride, showing its molecular framework including hydroxyl groups, amine group, and hydrochloride salt.*

FDA Label Image

Structure (51662 1681 Structure 2)

Chemical structure diagram showing a sugar molecule with hydroxyl groups and a water molecule (H2O), consistent with the structure of dextrose as part of dopamine hydrochloride in dextrose injection.*

FDA Label Image

Label (51662 1681 1 Rfid)

A pharmaceutical label featuring a GS1 DataMatrix barcode and several GS1 Application Identifiers including product code (01), expiration date (17), batch/lot number (21), and additional identifier (10). The label states 'SEE MANUFACTURER'S INSERT' and notes distribution by HF Acquisition Co., LLC in Mukilteo, WA 98275. The text 'RX ONLY' is printed vertically beside the barcode.*

FDA Label Image

Label (51662 1681 2 Pouch)

Label for Dopamine HCl in 5% Dextrose Injection, USP 400 mg/250 mL (1,600 mcg/mL) in a 250mL bag. It includes the NDC 51662-1681-2, lot number, and expiration date 2030-09-19. Provided by HF Acquisition Co LLC, DBA HealthFirst, the label details ingredient concentrations, storage instructions, and usage warnings for this intravenous injection solution.*

FDA Label Image

Label (51662 1681 3 Case)

Label for dopamine hydrochloride in 5% dextrose injection, USP 400 mg/250 mL (1.6 mg/mL) in a 250 mL bag. The label includes NDC 51662-1681-3, lot number, expiration date 2030-09-19, and manufacturer/distributor HF Acquisition Co LLC, Mukilteo, WA. The single-dose container is for intravenous use and includes usage warnings and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.